FDA: New Labeling for PPI Medications Used for Acid Reflux
There were many news stories this week about a new Food and Drug Administration (FDA) warning about the use of Proton Pump Inhibitor or PPI medications used to treat Gastroesophageal Reflux Disease or GERD. The FDA has decided to add more information to the medication labels warning of an increased risk of fractures associated with the long term use of these medications. The information is not new. What is new is the recommendations given to doctors and consumers about the safety and use of these medications.
You are probably more familiar with the brand names of PPI's such as Prevacid, Nexium, Prilosec, Zegrid and Protonix, amoung others. If you are taking a PPI medication, it is important to keep taking the medication as directed by your doctor. As you have follow up appointments to monitor your condition, ask the doctor if you should stay on the medication, change the dose or stop taking the PPI.